MARATTO

article · Plant Science Today

Ethnobotanical survey of medicinal plants claimed by traditional herbal practitioners to manage digestive disorders in an oasis of Tafilalet-Morocco

20242 citationsOpen accessUniversité Moulay Ismail de Meknes

Abstract

To highlight the different medicinal plants traditionally used by the local citizens of the Tafilalet region to treat digestive disorders, floristic and ethnobotanical research was conducted in that region from April 2021 to July 2021. The ethnobotanical surveys were carried out using questionnaire sheets with 30 herbalists in different areas in Tafilalet (Errachidia, Rissani, and Erfoud). This study enabled us to gather extensive information about local traditions of therapeutic practices using medicinal plants on one hand and to make a floristic catalog of the same plants on the other hand. Thus, this work ended up by identifying 48 species belonging to 28 floristic families in which Apiaceae and Lamiaceae are the most dominant, and the Ranunculaceae exhibited the highest family use value (FUV=0.667). Of the species listed, Nigella sativa L. has the highest use value (UVs=0.677). The highest relative citation frequency is noted for Rosmarinus officinalis L. and Nigella sativa (RFC=0.233). The leaves (29.82%) are the most used part of plants, and a large part of the remedies are used in powder form (35%) and infusion (28%). The most treated digestive disorders are gastritis (26%) and abdominal pain (24%).

Research topics

  • African Botany and Ecology Studies
  • Ethnobotanical and Medicinal Plants Studies
  • Water management and technologies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.14719/pst.3357

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.